The Lancet Microbe
News
24 Mar 2021
Study shows that antibody longevity varies widely from 40 days to as long as several decades and not everyone who has recovered from COVID-19 is immune from reinfection. Individuals with low levels of neutralising antibodies may still be protected if they have robust T-cell immunity. Blood tests and a computer algorithm suggest annual vaccinations might be needed for some individuals to prevent future outbreaks of COVID-19.
Events
Sorry, no events coming up for this topic.
Researchers
Sorry, no researchers coming up for this topic.
Giants in history
Sorry, no researchers coming up for this topic.